Swaddling to Improve Neurodevelopment for Preterm Babies
Primary Purpose
Preterm Birth, Neurodevelopmental Disorders
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Novel Swaddle
Sponsored by
About this trial
This is an interventional supportive care trial for Preterm Birth focused on measuring Preterm, Brain, Neurodevelopment, Swaddling
Eligibility Criteria
Inclusion Criteria:
- Born very preterm (<32 weeks postmenstrual age (PMA))
- At least 12 hours and less than 2 months old
- Expected to survive > 3 days
- No congenital anomaly or genetic disorder with expected survival less than term equivalent
- No malformations requiring surgery within 1 month of life
- Central intravenous lines removed
- Approval of the primary neonatologist, ideally not a study team member, to approach family for consent
- Appropriate parent or guardian to provide informed consent
Exclusion Criteria:
- Life expectancy < 3 days
- Severe congenital anomaly or genetic disorder with life expectancy <40 weeks PMA
- Seizures
- Need for seizure medication
- Hypertension for age requiring medication
- Severe hematologic crisis such as disseminated intravascular coagulation
- Hydrops fetalis
- Clinical concern or diagnosis of toxoplasmosis, cytomegalovirus rubella or syphilis infection
- Clinical concern or diagnosis of severe acute respiratory distress syndrome coronavirus 2 (SARS CoV-2) or coronavirus disease (COVID-19)
- Central intravenous access and reliance on parenteral nutrition >50%
- Respiratory support greater than nasal canulae or nasal continuous positive airway pressure (CPAP) (i.e. ventilator dependent)
- Active infection, including need for antibiotics greater than 5 days (i.e. confirmed infection)
- Complex congenital heart disease
- Known chromosomal abnormalities
- Clinical or echocardiographic signs of symptomatic pulmonary hypertension
- Profound perinatal hypoxia-ischemia
- Receiving treatment for pain control
- Sustained tachypnea >80 breaths/minute
- Need for volume expansion or administration of inotropes
- No one available or willing to provide consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Conventional Swaddle
Novel Swaddle
Arm Description
The management of the non-intervention group is with a cotton swaddle that is standard of care. It represents a conventional standard management method using a swaddle made of cotton.
The Novel Swaddle is made of fabric consisting of 85% nylon and 15% polyurethane. This fabric provides heat retention, is hygroscopic and stretches in both longitudinal and transverse directions, thus more accurately replicating the intrauterine environment. The novel material is sewed into a bag shape.
Outcomes
Primary Outcome Measures
Change in Sleep-Wake Cycling Maturity as assessed by amplitude integrated EEG (aEEG) readings
Using aEEG, the Investigators will assess the presence or absence of mature sleep-wake cycling as defined as regular rhythmic sinusoidal variations of amplitude with a cycle greater than or equal to 20 minutes. Tracings with a cycling pattern that does not fit into a mature sleep-wake cycle for the majority of the tracing will be classified as intermediate.
Change in length of time spent in sleep
Using aEEG, the Investigators will assess the change in length of time (in minutes) spent in sleep.
Change in the number of awakenings in a 3 hour time period
Using aEEG, the Investigators will assess the change in number of awakenings in a 3 hour time period.
Change in voltage as assessed by aEEG) readings
Using aEEG, the Investigators will assess the change in voltage (measured in microvolts).
Change in ratio of active sleep and quiet sleep as assessed by amplitude integrated EEG (aEEG) readings
Using aEEG The Investigators will assess the time spent in active sleep (irregular and low in amplitude) and quiet sleep (regular and high in amplitude).
Change in Sleep-Wake Cycling Continuity as assessed by amplitude integrated EEG (aEEG) readings
Using aEEG The Investigators will examine the background activity on recordings to assess the presence or absence of isoelectric periods along with amplitude fluctuations. Tracings will be classified as continuous, discontinuous and borderline.
Secondary Outcome Measures
Behavioral Maturity as assessed by the NNNS
The NICU Network Neurobehavioural Scale (NNNS) is a standardized clinical assessment tool used to assess neurological integrity and organization in a single, structured clinical exam. Summary scores are created for neurobehavioral domains including: habituation, attention, handling, quality of movement, self-regulation, non optimal reflexes, asymmetrical reflexes, stress/abstinence, arousal, hypertonicity, excitability, and lethargy. 13 summary scores will be generated.
Change in General Movements as assessed by the GMA
Prechtl's General Movement Assessment (GMA) is a clinical assessment tool that classifies writhing movements in preterm infants. Specifically, classification of writhing movements will be made as cramped synchronous, poor repertoire with cramped synchronicity, or poor repertoire.
Full Information
NCT ID
NCT04715451
First Posted
January 14, 2021
Last Updated
August 7, 2023
Sponsor
Johns Hopkins University
Collaborators
The Thomas Wilson Sanitarium for Children of Baltimore City
1. Study Identification
Unique Protocol Identification Number
NCT04715451
Brief Title
Swaddling to Improve Neurodevelopment for Preterm Babies
Official Title
A Novel Swaddling Method To Improve Developmental Care for Preterm Babies
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
December 1, 2023 (Anticipated)
Primary Completion Date
May 2025 (Anticipated)
Study Completion Date
May 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
The Thomas Wilson Sanitarium for Children of Baltimore City
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigators will test a new medical grade swaddling system for optimal and more appropriate positioning for preterm infants. This is a trial focused on sleep state, state regulation and long-term neurodevelopment. The central hypothesis is that this novel swaddling method will promote sleep and an optimal sleep-wake cycle, while also improving the neurodevelopment of preterm infants. It is proposed that adequate positioning and secondary feedback of natural movement of arms and legs stimulates and fosters normal brain development.
Detailed Description
Throughout pregnancy, the fetus is encouraged to develop by maintaining proper flexed posture in the uterus and freely moving its arms and legs against the flexible boundaries of the womb. However, when born too early, preterm infants lose the natural boundaries of the womb that support this flexor positioning and movement support. In addition preterm infants undergo stress because of essential treatments in neonatal intensive care units and exposure to the extrauterine environment. To support the development of preterm infants, cotton wraps are often used to maintain appropriate body positioning. Swaddling helps maintain continuous and adequate body positioning which aids and provides a stable sleep environment and encourages muscle tone. However, traditional swaddling is challenging in preterm infants and preterm infants frequently become unswaddled. It is fraught with difficulties related to the neonatal care and monitoring preterm infants receive due to the prematurity. In addition, this stiff material does not provide the same sensory experience as the flexible boundaries of the womb. In response to this challenge, The Investigators developed a new medical grade swaddling system for optimal and more appropriate positioning and natural movement. Here, The Investigators outline a trial focused on sleep state, state regulation and long-term neurodevelopment. The central hypothesis is that this novel swaddling method will promote sleep and an optimal sleep-wake cycle, while also improving the neurodevelopment of preterm infants. It is proposed that adequate positioning and secondary feedback of natural movement of arms and legs stimulates and fosters normal brain development. The Investigators will clinically evaluate sleep at the level of amplitude-integrated electroencephalograph (aEEG) activity and perform the Prechtl's Assessment of General Movements (GMA) to assess spontaneous writhing and fidgety movements, which predicts the future neurodevelopment of preterm babies. The Investigators will also perform the Neonatal Intensive Care Unit (NICU) Network Neurobehavioural Scale (NNNS) as a standardized assessment of neurological integrity and organization. The goal is to provide early intervention to improve development in preterm infants.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth, Neurodevelopmental Disorders
Keywords
Preterm, Brain, Neurodevelopment, Swaddling
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Conventional Swaddle
Arm Type
No Intervention
Arm Description
The management of the non-intervention group is with a cotton swaddle that is standard of care. It represents a conventional standard management method using a swaddle made of cotton.
Arm Title
Novel Swaddle
Arm Type
Experimental
Arm Description
The Novel Swaddle is made of fabric consisting of 85% nylon and 15% polyurethane. This fabric provides heat retention, is hygroscopic and stretches in both longitudinal and transverse directions, thus more accurately replicating the intrauterine environment. The novel material is sewed into a bag shape.
Intervention Type
Other
Intervention Name(s)
Novel Swaddle
Intervention Description
A novel swaddling method.
Primary Outcome Measure Information:
Title
Change in Sleep-Wake Cycling Maturity as assessed by amplitude integrated EEG (aEEG) readings
Description
Using aEEG, the Investigators will assess the presence or absence of mature sleep-wake cycling as defined as regular rhythmic sinusoidal variations of amplitude with a cycle greater than or equal to 20 minutes. Tracings with a cycling pattern that does not fit into a mature sleep-wake cycle for the majority of the tracing will be classified as intermediate.
Time Frame
32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Title
Change in length of time spent in sleep
Description
Using aEEG, the Investigators will assess the change in length of time (in minutes) spent in sleep.
Time Frame
32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Title
Change in the number of awakenings in a 3 hour time period
Description
Using aEEG, the Investigators will assess the change in number of awakenings in a 3 hour time period.
Time Frame
32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Title
Change in voltage as assessed by aEEG) readings
Description
Using aEEG, the Investigators will assess the change in voltage (measured in microvolts).
Time Frame
32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Title
Change in ratio of active sleep and quiet sleep as assessed by amplitude integrated EEG (aEEG) readings
Description
Using aEEG The Investigators will assess the time spent in active sleep (irregular and low in amplitude) and quiet sleep (regular and high in amplitude).
Time Frame
32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Title
Change in Sleep-Wake Cycling Continuity as assessed by amplitude integrated EEG (aEEG) readings
Description
Using aEEG The Investigators will examine the background activity on recordings to assess the presence or absence of isoelectric periods along with amplitude fluctuations. Tracings will be classified as continuous, discontinuous and borderline.
Time Frame
32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Secondary Outcome Measure Information:
Title
Behavioral Maturity as assessed by the NNNS
Description
The NICU Network Neurobehavioural Scale (NNNS) is a standardized clinical assessment tool used to assess neurological integrity and organization in a single, structured clinical exam. Summary scores are created for neurobehavioral domains including: habituation, attention, handling, quality of movement, self-regulation, non optimal reflexes, asymmetrical reflexes, stress/abstinence, arousal, hypertonicity, excitability, and lethargy. 13 summary scores will be generated.
Time Frame
37 weeks postmenstrual age
Title
Change in General Movements as assessed by the GMA
Description
Prechtl's General Movement Assessment (GMA) is a clinical assessment tool that classifies writhing movements in preterm infants. Specifically, classification of writhing movements will be made as cramped synchronous, poor repertoire with cramped synchronicity, or poor repertoire.
Time Frame
32 weeks postmenstrual age and 37 weeks postmenstrual age
10. Eligibility
Sex
All
Minimum Age & Unit of Time
24 Weeks
Maximum Age & Unit of Time
37 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Born very preterm (<32 weeks postmenstrual age (PMA))
At least 12 hours and less than 2 months old
Expected to survive > 3 days
No congenital anomaly or genetic disorder with expected survival less than term equivalent
No malformations requiring surgery within 1 month of life
Central intravenous lines removed
Approval of the primary neonatologist, ideally not a study team member, to approach family for consent
Appropriate parent or guardian to provide informed consent
Exclusion Criteria:
Life expectancy < 3 days
Severe congenital anomaly or genetic disorder with life expectancy <40 weeks PMA
Seizures
Need for seizure medication
Hypertension for age requiring medication
Severe hematologic crisis such as disseminated intravascular coagulation
Hydrops fetalis
Clinical concern or diagnosis of toxoplasmosis, cytomegalovirus rubella or syphilis infection
Clinical concern or diagnosis of severe acute respiratory distress syndrome coronavirus 2 (SARS CoV-2) or coronavirus disease (COVID-19)
Central intravenous access and reliance on parenteral nutrition >50%
Respiratory support greater than nasal canulae or nasal continuous positive airway pressure (CPAP) (i.e. ventilator dependent)
Active infection, including need for antibiotics greater than 5 days (i.e. confirmed infection)
Complex congenital heart disease
Known chromosomal abnormalities
Clinical or echocardiographic signs of symptomatic pulmonary hypertension
Profound perinatal hypoxia-ischemia
Receiving treatment for pain control
Sustained tachypnea >80 breaths/minute
Need for volume expansion or administration of inotropes
No one available or willing to provide consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lauren Jantzie, PhD
Phone
410-614-4135
Email
LJantzie@jhmi.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Shenandoah Robinson, MD
Phone
410-955-7851
Email
SRobin81@jhmi.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lauren Jantzie, PhD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
28675824
Citation
Kitase Y, Sato Y, Takahashi H, Shimizu M, Ishikawa C, Yamamoto H, Hayakawa M. A new type of swaddling clothing improved development of preterm infants in neonatal intensive care units. Early Hum Dev. 2017 Sep;112:25-28. doi: 10.1016/j.earlhumdev.2017.06.005. Epub 2017 Jul 1.
Results Reference
background
Learn more about this trial
Swaddling to Improve Neurodevelopment for Preterm Babies
We'll reach out to this number within 24 hrs